First evaluation of the anxiolytic-like effects of a bromazepam‑palladium complex in mice.

A significant fraction of patients are affected by persistent fear and anxiety. Currently, there are several anxiolytic drug options, however their clinical outcomes do not fully manage the symptoms. Here, we evaluated the effects of a bromazepam‑palladium derivative [2-{(7-bromo-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-5-il)pyridinyl-κ2-N,N}chloropalladium(II)], [(BMZ)PdCl2], on fear/anxiety and memory-related behavior in mice. For this, female Swiss mice were treated intraperitoneally (i.p.) with saline (NaCl 0.9%) or [(BMZ)PdCl2] (0.5, 5.0, or 50 μg/kg). After 30 min, different tests were performed to evaluate anxiety, locomotion, and memory. We also evaluated the acute toxicity of [(BMZ)PdCl2] using a cell viability assay (neutral red uptake assay), and whether the drugs mechanism of action involves the γ-aminobutyric acid type A (GABAA) receptor complex by pre-treating animals with flumazenil (1.0 mg/kg, i.p., a competitive antagonist of GABAA-binding site). Our results demonstrate that [(BMZ)PdCl2] induces an anxiolytic-like phenotype in the elevated plus-maze test and that this effect can be blocked by flumazenil. Furthermore, there were no behavioral alterations induced by [(BMZ)PdCl2], as evaluated in the light-dark box, open field, and step-down passive avoidance tests. In the acute toxicity assay, [(BMZ)PdCl2] presented IC50 and LD50 values of 218 ± 60 μg/mL and 780 ± 80 mg/kg, respectively, and GSH category 4. Taken together, our results show that the anxiolytic-like effect of acute treatment with [(BMZ)PdCl2] occurs through the modulation of the benzodiazepine site in the GABAA receptor complex. Moreover, we show indications that [(BMZ)PdCl2] does not promote sedation and amnesia and presents the same toxicity as the bromazepam prototype. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Mirella P S Vieira, Ozileudiane B S Silva, Gabriela F Souza, Gabriela T S Cavalcante, Fernanda M A Souza, Daniel L G Gitaí, Olagide W Castro, Dannyele C S P Nicácio, Axel H R Cofré, Mariana A Amorós, Artur V Silva, Geraldo José da Silva Neto, Allysson H Q Silva, Walleska B Z G B Correia, Janaína A Junkes, Filipe S Duarte, Jéssica S Guedes, Fábio C S Nogueira, Mario R Meneghetti, Marcelo Duzzioni. First evaluation of the anxiolytic-like effects of a bromazepam‑palladium complex in mice. Journal of inorganic biochemistry. 2022 Dec;237:112012

Mesh Tags

Substances

PMID: 36162209

search → result